Ironwood Pharmaceuticals, Inc. Class A
(NASDAQ: IRWD)

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines. The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal diseases. Its two GC-C agonists are linaclotide and IW-9179.

3.465 s

-0.265 (-7.10%)
Range 3.455 - 3.800   (9.99%)
Open 3.725
Previous Close 3.730
Bid Price 10.730
Bid Volume 8
Ask Price 10.740
Ask Volume 9
Volume 613,463
Value -
Remark s
Delayed prices. Updated at 06 Dec 2025 00:05.
Data powered by
View All Events

About Ironwood Pharmaceuticals A

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines. The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal diseases. Its two GC-C agonists are linaclotide and IW-9179.

Loading Chart...

Please login to view stock data and analysis